Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06320899

Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases

The purpose of this multi-center, randomized, clinical study is to show that the treatment of degenerative lumbar spine with high- or mid-flex rods is not inferior to the treatment with low-flex rods in terms of clinical and safety-related results.

The primary aim is to compare the reduction in back pain after the treatment with high- or mid-flex rods with that after treatment with low-flex rods. Secondary, the functionality after treatment with high- or mid-flex rods will be compared to that after treatment with low-flex rods.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Spital Aarberg, Aarberg, Switzerland

Loading trial locations.

About this study

Dynamic stabilization systems for the lumbar spine are no novelty. The SpineShape System IV builds on the experience of previous systems and attempts to provide additional benefits primarily through three different and relatively elastic rod stiffnesses. 126 subjects with degenerative symptoms in 1 to 2 segments of the lumbar spine L1 to S1 will be recruited. The participants will be randomized in a 1:1:1 ratio to undergo implantation of either the elastic (experimental product group 1), medium (experimental product group 2) or stiff rod (comparison product group).

The aim of the study is to show that the treatment of degenerative lumbar spine with elastic or medium rod variants is not inferior to treatment with hard rods in terms of clinical and safety-related results. This is checked by completing a questionnaire before the surgical procedure and 3 months, 12 months, 24 months and 60 months after the surgical procedure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • degenerative symptoms in 1 to 2 segments in the lumbar spine L1-S1
  • signed informed consent of participant
  • confirmation of the participant that the attendance of follow-up visits are intended
  • Body-Mass-Index < 32
  • Pedicle screw axis distance < 30mm
  • one or more of the following indications:
  • (dynamic) stenosis in the spinal canal
  • neuroforaminal stenosis
  • facet joint syndrome / spondylarthrosis
  • discopathy (recurrent disc hernia)
  • degenerative spondylolisthesis (Meyerding <1)
  • instability (hypermobility with antelishtesis, hypomobility with retrolisthesis if decompressed)

Exclusion criteria

  • missing bone structure, e.g. due to congenital anomalies or sever anatomical deformities that make anchoring of the implant impossible
  • damaged structural tissue, e.g. due to a bone fracture
  • application to the thoracic or cervical spine
  • pronounced idiopathic scoliosis
  • spondylolisthesis > Meyerding grad 1
  • isthmic spondolylysis
  • bone tumor
  • osteochondrosis modic type I, II or III
  • osteoporosis, which could impair screw anchoring
  • history with third party implants
  • patients with an active local or systemic infection
  • known allergy to titatnium alloys
  • skeleton in growth (epiphyseal joints not closed)
  • severe muscular neuronal or vascular disease
  • immunosuppresive therapy
  • long-term therapy with cortisone
  • heavy smokers (regular consumption of more than six cigarettes per day), drug addicts and alcoholics
  • chronic pain patients
  • incapable of judgment or emergency situation
  • implantation during pregnancy

Treatment and study plan

SpineShape System IV straight rod elastic

Device

Implantation of SpineShape System IV straight rod elastic

SpineShape System IV straight rod medium

Device

Implantation of SpineShape System IV straight rod medium (mid-flex)

SpineShape System IV straight rod stiff

Device

Implantation of SpineShape System IV straight rod stiff (low-flex)

Primary outcomes

  1. Visual Analogue Scale (VAS) lower back pain

    Time frame: 24 months post-implantation

    self reported back pain intensity using Visual Analogue Scale system. 0 "no pain" to 10 "worst possible pain"

Secondary outcomes

  1. Visual Analogue Scale (VAS) leg pain

    Time frame: 3, 12, 24, 60 months post-implantation

    self reported leg pain intensity using Visual Analogue Scale system. 0 "no pain" to 10 "worst possible pain"

  2. walking duration

    Time frame: 3, 12, 24, 60 months post-implantation

    self reported walking duration in 5 categories (0-5 min, 6-15 min, 16-30 min, 31-60 min and >60min)

  3. medication consumption

    Time frame: 3, 12, 24, 60 months post-implantation

    use of none, mild pain medication, non-steroidal anti-inflammatory drugs, opioids, and/or antidepressiva documented in patient's health records

  4. adverse events

    Time frame: after 3, 12, 24, 60 months post-implantation

    adverse events related to the device (e.g. screw loosening, screw breakage, torn rod, slipped rod or too short rod)

  5. segmental mobility index level

    Time frame: 3, 12, 24, 60 months post-implantation

    measuring the segmental mobility at index level to verify the preservation of the mobility. an average mobility per segment of >1° is considered a success

  6. ability to work/ activity (for retirees)

    Time frame: 3, 12, 24, 60 months post-implantation

    self reported ability to work or activity (for retirees) in 5 categories (0%, 25%, 50%, 75%, 100%)

Study contacts

Contact information is provided by the study sponsor or research team.

Sarah Abramovic

CONTACT

[email protected]

+41448669280

Sponsors and collaborators

Lead sponsor

SpineSave AG

Industry

Registry information

Official study title

Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases - a Prospective, Multicenter, Randomized Controlled Non-inferiority Study

Important dates

Study start
2024
Primary completion
2031
Study completion
2031
First posted
Mar 20, 2024
Registry last updated
Jun 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.